Does ECULIZUMAB Cause Haemoglobin abnormal? 466 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 466 reports of Haemoglobin abnormal have been filed in association with ECULIZUMAB (SOLIRIS). This represents 1.1% of all adverse event reports for ECULIZUMAB.
466
Reports of Haemoglobin abnormal with ECULIZUMAB
1.1%
of all ECULIZUMAB reports
31
Deaths
194
Hospitalizations
How Dangerous Is Haemoglobin abnormal From ECULIZUMAB?
Of the 466 reports, 31 (6.7%) resulted in death, 194 (41.6%) required hospitalization, and 10 (2.1%) were considered life-threatening.
Is Haemoglobin abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 466 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Haemoglobin abnormal?
RUXOLITINIB (500)
VENETOCLAX (248)
DARBEPOETIN ALFA (213)
ADALIMUMAB (207)
LENALIDOMIDE (172)
RITUXIMAB (157)
ERYTHROPOIETIN (154)
IBRUTINIB (148)
DEXAMETHASONE (147)
CYCLOPHOSPHAMIDE (122)
Which ECULIZUMAB Alternatives Have Lower Haemoglobin abnormal Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB